Last updated: 19 January 2024 at 6:12pm EST

Healthcare Capital Partners... Net Worth




The estimated Net Worth of Healthcare Capital Partners... is at least $47.8 Million dollars as of 17 January 2024. Healthcare Partners owns over 143,605 units of KalVista Pharmaceuticals Inc stock worth over $47,807,459 and over the last few years Healthcare sold KALV stock worth over $0.

Healthcare Partners KALV stock SEC Form 4 insiders trading

Healthcare has made over 5 trades of the KalVista Pharmaceuticals Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Healthcare bought 143,605 units of KALV stock worth $1,802,243 on 17 January 2024.

The largest trade Healthcare's ever made was buying 519,017 units of KalVista Pharmaceuticals Inc stock on 27 December 2023 worth over $6,466,952. On average, Healthcare trades about 177,187 units every 4 days since 2023. As of 17 January 2024 Healthcare still owns at least 4,459,651 units of KalVista Pharmaceuticals Inc stock.

You can see the complete history of Healthcare Partners stock trades at the bottom of the page.



Insiders trading at KalVista Pharmaceuticals Inc

Over the last 8 years, insiders at KalVista Pharmaceuticals Inc have traded over $74,823,944 worth of KalVista Pharmaceuticals Inc stock and bought 4,877,063 units worth $58,591,487 . The most active insiders traders include Holdings A/S Novo, Capital Management, L.P.Ra ..., and Rajeev M. Shah. On average, KalVista Pharmaceuticals Inc executives and independent directors trade stock every 19 days with the average trade being worth of $835,088. The most recent stock trade was executed by Benjamin L Palleiko on 6 September 2024, trading 15,625 units of KALV stock currently worth $167,500.



What does KalVista Pharmaceuticals Inc do?

kalvista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors.



What does KalVista Pharmaceuticals Inc's logo look like?

KalVista Pharmaceuticals Inc logo

Complete history of Healthcare Partners stock trades at KalVista Pharmaceuticals Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
17 Jan 2024 Healthcare Capital Partners...
Buy 143,605 $12.55 $1,802,243
17 Jan 2024
4,459,651
11 Jan 2024 Healthcare Capital Partners...
Buy 26,246 $12.72 $333,849
11 Jan 2024
4,316,046
8 Jan 2024 Healthcare Capital Partners...
Buy 137,700 $12.54 $1,726,758
8 Jan 2024
4,289,800
3 Jan 2024 Healthcare Capital Partners...
Buy 59,369 $12.14 $720,740
3 Jan 2024
4,152,100
27 Dec 2023 Healthcare Capital Partners...
Buy 519,017 $12.46 $6,466,952
27 Dec 2023
4,092,731


KalVista Pharmaceuticals Inc executives and stock owners

KalVista Pharmaceuticals Inc executives and other stock owners filed with the SEC include: